Kyowa Kirin Co.,Ltd.
4151 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 千代田区大手町一丁目９番２号
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Kyowa Kirin Co., Ltd. is a Japanese pharmaceutical company dedicated to addressing the unmet medical needs of patients and healthcare professionals. Guided by the core concept of "Commitment to Life," Kyowa Kirin emphasizes innovation and compassion in its mission to enhance the quality of life. With a unique history and a focus on advanced technologies, the company leverages its strengths to develop therapies that not only treat but inspire hope and happiness. Kyowa Kirin fosters a collaborative and passionate environment, believing in the power of teamwork to achieve extraordinary outcomes. The company is committed to making a meaningful difference in the lives of individuals, striving to be a leader in caring for life, one moment at a time.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-11 09:30 |
Inside Information Statement
臨時報告書
|
Japanese | 21.2 KB | |
| 2025-03-21 06:47 |
Regulatory News Service
訂正有価証券届出書（参照方式）
|
Japanese | 46.5 KB | |
| 2025-03-21 06:41 |
Inside Information Statement
臨時報告書
|
Japanese | 26.8 KB | |
| 2025-03-19 07:51 |
Prospectus
有価証券届出書（参照方式）
|
Japanese | 56.3 KB | |
| 2025-03-11 07:31 |
Annual Report
有価証券報告書－第102期(2024/01/01－2024/12/31)
|
Japanese | 4.0 MB | |
| 2025-03-11 07:31 |
Internal Control over Financial Reporting
内部統制報告書－第102期(2024/01/01－2024/12/31)
|
Japanese | 22.5 KB | |
| 2025-03-11 07:31 |
Regulatory News Service
確認書
|
Japanese | 8.2 KB | |
| 2024-11-14 07:30 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 26.6 KB | |
| 2024-10-31 07:30 |
Inside Information Statement
臨時報告書
|
Japanese | 26.1 KB | |
| 2024-10-11 08:30 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 24.9 KB | |
| 2024-09-12 08:32 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 28.2 KB | |
| 2024-08-09 08:30 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 26.1 KB | |
| 2024-08-01 08:31 |
Interim Report
半期報告書－第102期(2024/01/01－2024/12/31)
|
Japanese | 916.7 KB | |
| 2024-08-01 08:31 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | |
| 2024-08-01 08:30 |
Inside Information Statement
臨時報告書
|
Japanese | 23.9 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
GNI Group Ltd. | Japan | 2160 | |
|
Gour Medical | France | MLGML | |
|
Grifols S.A. | Spain | GRF | |
|
Grindeks | Latvia | GRD1R | |
|
Guerbet | France | GBT | |
|
Haemato AG | Germany | HAEK | |
|
Halychpharm | Ukraine | GFARM | |
|
Hamlet BioPharma AB | Sweden | HAMLET | |
|
Harm Reduction Group AB | Sweden | NOHARM | |
|
HEALIOS K.K. | Japan | 4593 |